Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number)
Filters
Ceftriaxone
Bahrain
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number)
20092022
Gonorrhea isolates tested for ceftriaxone by country in 2022
In 2022, Australia had the highest value (8,199) among 58 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Australia | 8,199 | +13.5% |
| 1 | Zambia (2020) | 244 | – |
| 1 | Viet Nam (2017) | 197 | +134.5% |
| 1 | Burkina Faso (2019) | 104 | – |
| 1 | Malaysia (2021) | 85 | -35.6% |
| 1 | Kyrgyzstan (2016) | 72 | – |
Similar Datasets
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion)
WHO (GASP_ISOLATESDSR_PROPORTION)
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
WHO (GASPRSAZM)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
WHO (GASPRSCFM)
Food safety JEE (score)
WHO (FOODSAFETY_JEE_SCORE)